Rethinking the effectiveness of hypomethylating agents in myelodysplastic syndromes: the 50%-2-year wall
Year: 2026
Type: article
Abstract: Not available.
Source: Haematologica
Authors: Howard Oster, Moshe Mittelman
Institutions: Tel Aviv University, Tel Aviv Sourasky Medical Center
Language: English
Subfield: Hematology
Field: Medicine
Domain: Health Sciences
Open Access status: gold
Estimated APC paid: $2,157
OpenAlex ID: W7125375727
FWCI:
Cites:
Cited by:
Related to: